Parthenogenesis and Human Assisted Reproduction.

Area of Science:

• Reproductive biology
• Stem cell research
• Regenerative medicine

Background:

• Parthenogenetic activation of human oocytes is a novel approach for research.
• It offers an alternative to creating embryos for assisted reproduction technologies, somatic cell nuclear transfer, and stem cell derivation.
• Clinically unusable oocytes from infertility treatments are a key resource.

Purpose of the Study:

• To review the creation of human parthenogenetic stem cell lines from clinically unusable oocytes.
• To discuss the potential applications of these stem cells in regenerative medicine.
• To highlight the importance of standardized artificial activation methodologies.

Main Methods:

• Review of existing literature on parthenogenetic activation of human and nonhuman oocytes.
• Focus on methods for creating parthenotes from clinically unusable oocytes.
• Analysis of stem cell derivation and developmental rates.

Main Results:

• Varying success rates reported for parthenote generation and embryo development across different activation methods.
• Potential for deriving clinical-grade pluripotent embryonic stem cells.
• Dependence of success on the availability of donated gametes.

Conclusions:

• Parthenogenetic activation of human oocytes provides a valuable resource for research and regenerative medicine.
• Derivation of human parthenogenetic stem cell lines from clinically unusable oocytes is feasible.
• Further standardization of activation methods is crucial for therapeutic applications.